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http:WHAT THIS PAPER ADDS
This technique, performed in a single center, appears to be feasible and safe. It offers the advantages of lap-
aroscopy and those of endovascular surgery, especially in the challenging conditions encountered during aortic
laparoscopic surgery. This approach using existing materials could make laparoscopic aortic surgery for occlusive
disease accessible for more vascular surgeons accustomed with laparoscopic surgery.Objective: This prospective study describes the feasibility and safety of a new clampless and sutureless aortic
anastomotic technique used during retroperitoneal laparoscopic aortobifemoral bypass in extensive aortoiliac
occlusive lesions. This is a case series of a previously published technique, demonstrating wider applicability of
the technique.
Materials and methods: Twelve patients underwent a clampless and sutureless laparoscopic bypass for TASC D
aortoiliac occlusive lesions using the EndoVascular REtroperitoneoScopic Technique (EVREST). Dissection of the
retroperitoneal space and the infrarenal aorta was performed laparoscopically. A bifurcated graft was inserted
into the retroperitoneal space. The main body of the graft was connected on the left side of the aorta by an intra-
and extra-aortic covered stent-graft. An aortic clamp was used temporarily on four patients because of excessive
bleeding when the connector was deployed. The femoral anastomoses were performed by classic open surgery.
Initial technical success, complications, and bypass patency were assessed.
Results: Median follow-up was 9.3 months. Median operative time was 265 minutes. Median duration of aorto-
prosthetic connection was 60 seconds. Thirty-day postoperative mortality was 0%. No major postoperative
complications were observed. All grafts were patent at the end of follow-up and there was no early or late
disruption of the proximal assembly.
Conclusions: EVREST greatly facilitates laparoscopic aortic surgery in occlusive disease with no need for suture or
clamping of the aorta. This technique performed in a single center on 12 patients, seems to be feasible and safe.
It offers the advantages of laparoscopy and those of endovascular surgery, especially in the challenging
conditions encountered during aortic laparoscopic surgery. Early experience supports procedural and initial
postprocedural safety and demonstrates proof-of-concept for EVREST.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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//dx.doi.org/10.1016/j.ejvs.2014.06.0362007.1 For bilateral and extensive aortoiliac lesions (TASC
D), surgical reconstruction is advised. The classic procedure
for aortobifemoral bypass is open surgery, which is associ-
ated with an overall mortality rate of 3.3%.2
In 1997, Yves-Marie Dion performed the ﬁrst totally
laparoscopic aortobifemoral bypass using a transperitoneal
approach.3 Since then, it has been considered to be a
minimally invasive alternative for treating aortoiliac occlu-
sive disease.47 The authors of the present study, and
others, have described the use of a totally retroperitoneal
laparoscopic approach as an alternative treatment in cases
Table 1. Demographic data, risk factors, and surgical data in 12
patients.
EVREST (N ¼ 12) EVREST (N ¼ 12)
N (%) Median (range)
Mean age (y) 58.2 e
Male/Female 10/2 e
Smoking 12 (100) e
Hypertension 10 (83) e
Hyperlipemia 8 (66) e
Diabetes 4 (33) e
Cardiac ischemia 5 (42) e
COPD 8 (67) e
Claudication 3 (25) e
Rest pain 6 (50) e
Tissue loss/gangrene 3 (25) e
Operative time (min) e 265 (180e330)
Deployment time (sec) e 60 (50e80)
Aorto-femoral time (min) e 53 (25e85)
Intensive care unit stay (h) e 32.4 (17e48)
Hospital stay (d) e 6.2 (3e8)
EVREST, EndoVascular REtroperitoneoScopic Technique.
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toprosthetic anastomosis is a challenging technique, making
it unpopular despite obvious advantages for patients.11
This study presents experience of totally retroperitoneal
laparoscopic aortobifemoral bypass performed on 12 pa-
tients using a clampless and sutureless technique for the
proximal anastomosis. The feasibility and safety of the
technique, called EndoVascular REtroperitoneoScopic
Technique (EVREST), is evaluated.
MATERIALS AND METHODS
Materials
From February 2012 to March 2013, EVREST was used in 12
patients who presented with TASC D aortoiliac occlusive
lesions for which endovascular revascularization was not
indicated. Ethical approval was obtained, and all patients
gave their informed consent before the procedure. Preop-
erative evaluation included cardiac stress test, pulmonary
function test, and supra-aortic trunk arterial Doppler im-
aging. Computed tomographic angiography was performed
on each patient to conﬁrm TASC D lesions, measure the
infrarenal abdominal aortic diameter, and evaluate aortoil-
iac calciﬁcation. The calciﬁcation was heavy in ﬁve patients
(42%), moderate in six (50%), and smooth in one (8%). In-
clusion criteria, based on the clinical complaint, clinical
ﬁndings, and angio CT scan issues, were Fontaine classiﬁ-
cation from stage II b (claudication <100 m) to IV (tissue
loss), and aorto-iliac TASC D lesions with at least 4 cm of
patent aorta beneath the renal arteries. Patients with a
heavily calciﬁed aorta and patency of the inferior mesen-
teric artery were not excluded. Exclusion criteria were jux-
tarenal thrombosis or thrombosed unilateral or bilateral
external iliac artery with patent aorta and internal iliac ar-
teries. Patients with TASC D lesions who were not candi-
dates for endovascular treatment were scheduled for
EVREST. During the same period, 26 patients underwent an
endovascular procedure to treat aortoiliac occlusive dis-
ease. Median patient age was 58.2 years (range 45e67
years), with ten males and two females. Median body mass
index (BMI) was 25.9 kg/m2 (range: 21.3e33.5). The EVREST
procedure was contraindicated in patients for whom an
endovascular procedure was an option or who were not
candidates for general anesthesia for any reason. In-
dications for surgery included disabling claudication in three
patients (25%), ischemic rest pain in six patients (50%), and
tissue loss or gangrene in three patients (25%). Three pa-
tients had a history of prior vascular surgery; one had a left
iliofemoral bypass and two had bilateral common or
external iliac endovascular reconstructions. All of the pa-
tients were active smokers (100%), ten had arterial hyper-
tension (83%), eight had hyperlipemia (66%), and four had
diabetes (33%). Five patients had a history of coronary
disease (42%), and eight (67%) had previous chronic
obstructive pulmonary disease (COPD) (Table 1). Preoper-
ative daily treatment included aspirin 80 mg for ﬁve pa-
tients and clopidogrel for two patients. Those treatments
were not interrupted prior to surgery. Aortic calciﬁcation,thrombus, plaque, and other morphologic variables were
evaluated by CT scan, and no morphological variables
affected the decision to perform EVREST. In order to apply
an endovascular sutureless anastomosis, the patient had to
have been diagnosed with TASC D aortoiliac occlusive le-
sions for which endovascular revascularization was not
indicated.
Initial technical success, complications, preoperative and
postoperative ankle brachial pressure index, assessment of
bypass patency, and integrity of the proximal assembly were
assessed, the latter by computed tomographic-angiography
at 1 week, 1 month, 6 months, and 1 year.
Surgical technique
This technique has been described in a previous study.12 To
perform EVREST, each patient was positioned, under gen-
eral anesthesia, in a 30 right lateral decubitus position. The
operator, ﬁrst assistant, and scrub nurse were on the left
side of the patient. The videomonitor was positioned on the
right side (Fig. 1). A pneumo-peritoneum was created using
a Veress needle introduced at the umbilicus. A 30 optical
system was ﬁrst inserted to check good positioning of three
trocars in the left retroperitoneal space. After exsufﬂation
of the pneumo-peritoneum, dissection of the retroperito-
neal space was performed by CO2 insufﬂation at a
maximum pressure of 14 mmHg, and by blunt dissection
with laparoscopic forceps. The left common iliac artery was
easily visualized above the psoas muscle and dissected with
monopolar electrocoagulation. The left ureter was then
visualized and the aorta was isolated up to the left renal
artery. One additional 12-mm trocar was placed between
the 11th rib and the umbilicus, to support a laparoscopic
aortic clamp (Aesculap, AG & Co KG Company). The aortic
clamp was left open in the retroperitoneal space, being
used as a retractor but ready to clamp the aorta in the
event of uncontrolled bleeding. A 14/7 mm diameter
Figure 1. Location of the laparoscopic ports, position of the pa-
tient, surgeon (S) and ﬁrst assistant (A).
402 B. Segers et al.bifurcated graft (Gelsoft Plus Bifurcate, Vascutek Terumo,
UK) was inserted into the retroperitoneal space through the
12-mm trocar. Under videoscopic control, the prosthetic
limbs were brought to the groins that had been previously
dissected. The tunnel to the right groin was made by vid-
eoscopic vision and ﬁnger dissection along the iliac vessels.
A laparoscopic grasping forceps was then introduced into
the retroperitoneal space through the tunnel underFigure 2. (A) Endurant stent-graft system introduced over the wire into
perioperative view. (B) Endurant stent graft is deployed into the aorta
(C) A non-compliant balloon is inﬂated to ensure sealing of the aorto-pr
case of bleeding.videoscopic vision. The limbs were sealed by ligation prior
to introduction of the bifurcated graft into the retroperi-
toneal space. An 18 gauge, 27 cm catheter needle (trans-
hepatic cholangiography catheter needle, Cook Medical
Inc., USA) was inserted through the left prosthetic limb into
the retroperitoneal space. The left lateral side of the infra-
renal aorta was then punctured at the level of the origin of
the inferior mesenteric artery (Video 1). A 0.03500 hydro-
philic guide wire (Terumo Corporation, Tokyo, Japan) was
positioned into the aorta. Heparin (100 IU/kg) was given
intravenously. A pigtail catheter was positioned for angi-
ography to localize the renal arteries. The hydrophilic guide
was changed for a stiff guide wire (Lunderquist, Cook
Medical Inc., USA). A 20 mm diameter and 80 mm length
iliac extension of an Endurant stent-graft system (Med-
tronic, Endovascular, Santa Rosa, CA, USA) was introduced
over the wire up to 4 cm into the aorta through the left
prosthetic limb of the bifurcated graft (Fig. 2, Video 2). The
left limb was sealed with a protected grasping mosquito
during the puncture of the aorta but no sealing was
necessary while the stent graft was introduced into the left
limb. The covered stent-graft, used as a connector, was
deployed into the infra-renal aorta and into the main body
of the bifurcated graft (Fig. 2). The deployment was
controlled by ﬂuoroscopy and by direct retroperitoneal
visualisation on the monitor. An 80 mm long, 20 mm
diameter non-compliant balloon (Z-Med-X, Nu MED Canada
inc., Cornwall, ON, Canada) was inﬂated at a controlled
maximum pressure of 2.5 atmospheres to ensure sealing of
the aorto-prosthetic junction and perfect deployment of the
endograft (Fig. 2, Video 3). For the ﬁrst two patients, athe aorta through the left prosthetic limb of the bifurcated graft:
and into the main body of the bifurcated graft: perioperative view.
osthetic junction. The aortic clamp is left open, ready to be used in
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tronik, Berlin, Germany) and a compliant balloon (Coda
balloon catheter, Cook Medical Inc., USA) were used, but
there was concern that the small balloon might lead to
restenosis in this cohort of heavy smokers so a switch was
made to the 20 mm balloon for the last 10 patients.
Restenosis was not observed at the 1-year computed
tomographic angiography in the two patients who received
the 10 mm balloon treatment (data not shown). The
femoral anastomoses were performed by classic open sur-
gery with 6/0 polypropylene running sutures (Fig. 3). Prior
to wound closure, videoscopic inspection was made of the
abdominal cavity to assess bowel viability. Two drains were
left in the retroperitoneal space for 24 hours, and one drain
in each femoral access site.
Supplementary videos related to this article can be found
online at http://dx.doi.org/10.1016/j.ejvs.2014.06.036.
The following are the Supplementary videos related to
this article:Video 1The left lateral side of the aorta is
punctured with a 27 cm catheter needle. Video 2Introduc-
tion of the covered stent graft over the wire into the aorta.
Video 3Final endoscopic vision.
Statistical analysis
Statistical analysis was done with Statistical Package for
Social Sciences Software (SPSS Inc, Chicago, IL, USA). Pre-
procedural and post-procedural ABIs were compared by
paired Student t test with Bonferroni correction. Statistical
signiﬁcance was set at p < .05.Figure 3. The femoral anastomoses are performed by classic open
surgery: postoperative 3-D reconstruction CT scan.RESULTS
All patients scheduled for EVREST underwent successful
procedures. The retroperitoneal laparoscopic approach to
the aorta was possible in every case. In each case, the
bifurcated graft was connected to the covered stent-graft
on the left side of the infrarenal aorta. Two connectors
were used for the fourth patient because the extra-aortic
overlap with the ﬁrst connector was less than 2 cm. All
procedures were conducted laparoscopically and no con-
version to open surgery was needed. Operative time was
deﬁned as the time elapsed from the initial incision to the
ﬁnal skin closure. EVREST operative time was an average of
265 minutes (range 180e330 minutes). Deployment time
was deﬁned as the time needed for deployment of the
stent-graft and for inﬂation of the balloon inside it. The
median deployment time was 60 seconds (range 50e80
seconds) and during that time the use of the aortic clamp
was necessary in four patients. The aorto-femoral time was
deﬁned as the time elapsed from the puncture of the aorta
to the completion of both femoral anastomoses. Median
aorto-femoral time was 53 minutes (range 25e85 minutes).
No disruptions of the aorta or inferior mesenteric artery
(IMA) were observed in the 12 cases. A bilateral femoral
endarterectomy prior to the femoral anastomosis was
necessary in two patients because of heavily calciﬁed le-
sions. A stenosis of the left superﬁcial femoral artery was
concomitantly treated by endovascular surgery in one pa-
tient. Average blood loss was 680 mL (range 200e1400 mL).
The average transfusion volume (cell-saver) was 360 mL
(range 100e900 mL). Median intensive care unit stay was
32.4 hours (range 17e48 hours). All patients received
intravenous analgesia followed by oral analgesics. No
epidural catheter or patient-controlled analgesia pumps
(PCA) were needed. Postoperative pain was clinically eval-
uated as moderate in nine patients and low in three pa-
tients. All patients had a nasogastric tube but it was
removed at the end of the procedure in all cases. Median
24-hour diuresis was 1390 mL (range 900e2100 ml). No
major postoperative complications or deaths were
observed. None of the patients needed postoperative sur-
gical revision. The median hospital stay was 6 days. Average
hospital stay was 6.2 days (range 3e8 days) (Table 1). All of
the patients had a quick recovery with minimal wound pain.
There was no postoperative bowel dysfunction. Post-
operative medication consisted of oral aspirin (160 mg
daily). The 30-day postoperative mortality rate was 0% (0/
12). Patency was evaluated by clinical examination, ankle
brachial index, and computed tomographic-angiography. All
grafts were patent at a mean follow-up of 9.3 months
(range 1e17 months), and there was no early or late
disruption of the proximal assembly. The ankle brachial
pressure index was improved in all cases. Primary patency
rate was 100%. In one patient, the control angio-CT at 1
week showed a paraprosthetic retroperitoneal hematoma
of 6  10 cm, which did not require additional surgery. The
size of the hematoma had decreased signiﬁcantly at 3-
month computed tomographic-angiography (Fig. 4). Two
404 B. Segers et al.patients underwent limited amputation of toes and one
patient had an amputation of the calcaneum. One patient
underwent a right femoropopliteal bypass 9 months after
EVREST. One patient died at 6 months from acute respira-
tory failure, with a patent bypass.DISCUSSION
Since 2004, the authors have performed several retroperi-
toneal aortobifemoral bypasses using a short left-sided
transverse incision. This procedure, described by Charles
Rob in 1963,13 is not very popular because of the difﬁculties
encountered in exposing the aorta. Using a surgical
retractor system (Condor GmbH Medicaltechnik, Germany),
the procedure remains challenging but feasible.14 Increased
experience has led to smaller incisions and this, coupled
with the laparoscopic skills of the authors, made it feasible
to attempt a retroperitoneal laparoscopic approach. Some
patients successfully underwent total laparoscopic retro-
peritoneal aortobifemoral bypass.9
The most popular method for laparoscopic aortobife-
moral bypass is the pre-renal transperitoneal
approach.35,15 However, regardless of the technique
used,35,8,9,15 the aortoprosthetic anastomosis is a major
challenge that makes it unpopular despite obviousFigure 4. Evolution of a paraprosthetic retroperitoneal hematoma.
One week (A) and 3 months (B) postoperative computed tomo-
graphic angiography.advantages for the patients.15 In a study of laparoscopy-
assisted aneurysm resection, Kolvenbach et al. reported
signiﬁcant reductions in cytokine release supporting the
notion that video-assisted surgery is less invasive and in-
duces less tissue trauma compared with conventional sur-
gery.16 Vascular laparoscopic experts agree that the learning
curve is long, that a mini-laparotomy is often needed to
complete the aortic anastomosis, and that new materials
are needed to make aortic suture more feasible.4,5,17 Some
vascular surgeons have presented new devices to facilitate
aortic suture but those materials were generally used only
in vitro, on pigs and cadavers, or only by the authors
themselves.17,18
Connecting blood vessels today is done mostly the same
way with sutures as it was 100 years ago, when the French
surgeon Alexis Carrel described the technique in 1902.19
This standard anastomotic technique requires a large
exposure, circumferential dissection, and clamping of ves-
sels. Moreover, classical surgical access can be quite difﬁcult
and time-consuming especially with patients who have
heavily calciﬁed vessels.20 These concerns are all the more
true for laparoscopic aortic surgery.
In 2007, Lachat21 published the VORTEC technique (Via-
bahn Open Revascularisazion TEChnique), which is a
clampless and sutureless method that appears to be faster,
safer, and easier than classic arterial sutures for complex
anastomoses in open surgery. Lachat described his experi-
ence of more than 300 cases in which he encountered no
major bleeding or leaks.22 This technique represents a sig-
niﬁcant improvement over traditional vascular anastomotic
surgical techniques.
The present authors decided to apply this technique to
total retroperitoneal laparoscopic aortobifemoral bypass.12
Patients were selected based on their clinical stage (Fon-
taine classiﬁcation) and on computed tomographic angiog-
raphy. Inclusion criteria were Fontaine classiﬁcation from
stage II b (claudication <100 m) to IV (tissue loss), and
aorto-iliac TASC D lesions with at least 4 cm of patent aorta
beneath the renal arteries. Heavily calciﬁed aorta and
patency of inferior mesenteric artery were not exclusions
for the technique (Table 2). Exclusion criteria were jux-
tarenal thrombosis or thrombosed unilateral or bilateral
external iliac artery with patent aorta and internal iliac
arteries.
The aorta was clamped temporarily in four patients (33%)
because of excessive bleeding when the connector was
deployed. The clamp was removed when the non-compliant
balloon was inﬂated into the connector. Median blood loss
was less than that described for open surgery.23 Operative
mortality was 0% and there were no complications during
surgery. It is important to keep in mind that conversion to
open surgery with a short left-sided transverse incision is
always possible if technical difﬁculties arise during the
procedure.
There were no endoleaks at 9 months follow-up. The
radial force of the endograft (which is not at its maximal
diameter at the aortic wall passage) might explain the
absence of endoleak during diastole. All of the patients
Table 2. Imaging data.
Patient Previous surgery (thrombosed) Level of lesions Type of
lesions
Aortic
calciﬁcations
1 Kissing stents A, Bilateral CIA T/ES M
2 Bilateral ilio femoral bypass þ
femoro-femoral bypass
Bilateral CIA, Bilateral EIA T H
3 e A, Bilateral CIA and EIA T H
4 e Bilateral CIA and EIA T H
5 Bilateral CIA stents A, Bilateral CIA T H
6 e Left CIE/EIA
Right EIA
T/S M
7 e Bilateral CIA/EIA T/S H
8 e A, CIA, EIA T M
9 e Left CIA and EIA/Right CIA and EIA T/S M
10 e Bilateral EIA/Bilateral CIA T/S M
11 e A, Bilateral CIA, Left EIA T M
12 e A, CIA T M
A: Terminal aorta, CIA: Common iliac arteries, EIA: External iliac arteries, T: Thrombosis, S: Stenosis, ES: Extensive stenosis, H: Heavy, M:
Moderate.
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very-hard-to-break rigid aortic wall frame, which would be
expected to prevent further tearing. However, a direct
hammer effect on the aortostomy inferior edge leading to a
leak could be an issue for patients with soft, non-calciﬁed
aorta.
The median operative time was close to those published
in large laparoscopic series,6,7 but it must be considered
that the last two patients had operative times close to the
shorter range of those published series. With increased
experience, the authors believe that the operative time for
the procedure will decrease signiﬁcantly.
Median hospital stay (6 days) and mean hospital stay (6.2
days, range 3e8 days) were shorter than those published in
a study dealing with a comparable population who under-
went open surgery (mean 12.8 days, range 6e81 days) or
laparoscopic surgery (mean 7 days, range 3e19 days).23
Lachat, who used an endograft connector in open surgery
for aortoiliac occlusive disease with heavy calciﬁed aorta,
reported a mean hospital stay of 16.5  12 days.22 The
prolonged discharge time was related to inexperience, so-
cial issues, and severe comorbidities associated with pa-
tients with TASC D lesions.Conclusions
EVREST greatly facilitates laparoscopic aortic surgery in
occlusive disease with no need for suturing or clamping of
the aorta. The most attractive feature of EVREST is that it
allows surgeons to avoid performing the technically chal-
lenging aortoprosthetic anastomosis. This technique, per-
formed in a single center on 12 patients, seems to be
feasible and safe. It offers the advantages of both laparos-
copy and endovascular surgery, especially in the challenging
conditions encountered during aortic laparoscopic surgery.
This approach, using existing materials, could make lapa-
roscopic aortic surgery for occlusive disease accessible to
more vascular surgeons accustomed to laparoscopic
surgery.For patients who are candidates for an aortobifemoral
bypass, the authors now propose EVREST as an alternative
to an open procedure.
More patients are required to assess the value of this
promising technique. As for other new techniques, the
reproducibility and long-term outcomes of patients treated
with EVREST will need to be evaluated, preferably in
multicenter studies. However, this early experience sup-
ports procedural and initial postprocedural safety and
demonstrates proof of concept for EVREST.
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